Indivior Pharmaceuticals Inc
Health
Performance
4.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Indivior Pharmaceuticals Inc stock rating and score history

All changes in ratings, performance and outlook tracked over time.

14.07.2026
Sliding into average ground. Desperately needs a real boost.
11.07.2026
Risk creeping up. Stability not bulletproof anymore.
21.04.2026
Outperforming hard. Momentum locked in.
20.08.2025
Climbing out. Risks fading, but not out of the woods.
INDV
Indivior Pharmaceuticals Inc
40.45
+0.00%
4.3
Sell
Buy
Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Indivior Pharmaceuticals Inc do? Business model and key facts

Get the full picture of Indivior Pharmaceuticals Inc: what it builds, where it operates, and how it makes money.

Indivior Pharmaceuticals Inc Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 838

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.

shop
Company facts
Joseph J. Ciaffoni
CEO
838
Employees worldwide
shop
Performance
150%
Last 12 months
283.41%
Last 5 years
shop
Growth
$1.24B
Revenue year
$210.00M
Net income
shop
Valuation
$5.06B
Market Cap
21.36
Price/Earnings Ratio

Stocks related to Indivior Pharmaceuticals Inc

Selected based on industry alignment and relative market positioning.

AMRX
Amneal Pharmaceuticals, Inc.
17.75
-1.93%
5.0
Sell
Buy
Amneal Pharmaceuticals, Inc.
LNTH
Lantheus Holdings, Inc.
104.61
-3.09%
5.3
Sell
Buy
Lantheus Holdings, Inc.
RDY
Dr. Reddy's Laboratories Limited
11.38
-9.39%
3.6
Sell
Buy
Dr. Reddy's Laboratories Limited
SUPN
Supernus Pharmaceuticals, Inc.
46.94
-1.94%
4.4
Sell
Buy
Supernus Pharmaceuticals, Inc.
AVDL
Avadel Pharmaceuticals plc
21.64
+0.00%
6.7
Sell
Buy
Avadel Pharmaceuticals plc

Events and news impacting Indivior Pharmaceuticals Inc stock

Earnings, coporate decisions and industry developments that can affect the share price.

Indivior Pharmaceuticals Inc fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.